FDA Warns Compounder Over Unsterile Procedures, GMP Failures

Drug Industry Daily
A A
The FDA sent a warning letter to Ranier’s Compounding Laboratory, based in Jeannette, Pa., noting serious deficiencies in sterile procedures and GMPs.

To View This Article:

Login

Subscribe To Drug Industry Daily